Societe Generale Reaffirms a Buy Rating on Shire PLC (LON:SHP) and GBX 8000.00 Target; Loring Wolcott & Coolidge Fiduciary Advisors Llp Has Increased By $500,700 Its Wabtec (WAB) Position

November 29, 2017 - By Linda Rogers

Loring Wolcott & Coolidge Fiduciary Advisors Llp increased Wabtec Corp (WAB) stake by 6.69% reported in 2017Q2 SEC filing. Loring Wolcott & Coolidge Fiduciary Advisors Llp acquired 6,676 shares as Wabtec Corp (WAB)’s stock declined 6.73%. The Loring Wolcott & Coolidge Fiduciary Advisors Llp holds 106,494 shares with $8.03 million value, up from 99,818 last quarter. Wabtec Corp now has $7.19B valuation. The stock increased 2.98% or $2.17 during the last trading session, reaching $74.86. About shares traded. Westinghouse Air Brake Technologies Corp (NYSE:WAB) has risen 7.39% since November 29, 2016 and is uptrending. It has underperformed by 9.31% the S&P500.

The broker have set price target of GBX 8000.00 on Shire PLC (LON:SHP) shares. This is 113.25% from the previous close. In a research note revealed to clients and investors on 29 November, Societe Generale restate their Buy rating on shares of SHP.

Among 26 analysts covering Shire PLC (LON:SHP), 21 have Buy rating, 1 Sell and 4 Hold. Therefore 81% are positive. Shire PLC has GBX 8000 highest and GBX 214 lowest target. GBX 5029.67’s average target is 34.75% above currents GBX 3732.5 stock price. Shire PLC had 391 analyst reports since July 24, 2015 according to SRatingsIntel. On Friday, April 15 the stock rating was maintained by RBC Capital Markets with “Outperform”. The firm has “Buy” rating by Citigroup given on Wednesday, May 17. The rating was maintained by HSBC on Wednesday, March 2 with “Buy”. The rating was maintained by Deutsche Bank with “Buy” on Monday, June 13. On Monday, October 3 the stock rating was maintained by JP Morgan with “Overweight”. Bernstein maintained Shire PLC (LON:SHP) rating on Monday, December 14. Bernstein has “Outperform” rating and GBX 6000 target. The firm has “Buy” rating given on Wednesday, May 3 by Jefferies. The firm has “Outperform” rating given on Wednesday, May 3 by Credit Suisse. Bernstein maintained it with “Outperform” rating and GBX 5000 target in Monday, March 7 report. The firm has “Conviction Buy” rating by Goldman Sachs given on Friday, November 24.

Shire plc is a biotech company focused on serving people with rare diseases and other specialized conditions. The company has market cap of 33.86 billion GBP. The Company’s segment is engaged in research, development, licensing, manufacturing, marketing, distribution and sale of specialist medicines. It has a 28.11 P/E ratio. It focuses its development resources on projects in various therapeutic areas , including Neuroscience, Ophthalmology, Hematology, Oncology, Immunology, Gastrointestinal (GI)/Metabolic/Endocrinology Diseases.

About 428,336 shares traded. Shire PLC (LON:SHP) has 0.00% since November 29, 2016 and is . It has underperformed by 16.70% the S&P500.

Among 13 analysts covering Wabtec (NYSE:WAB), 7 have Buy rating, 0 Sell and 6 Hold. Therefore 54% are positive. Wabtec had 25 analyst reports since December 21, 2015 according to SRatingsIntel. The firm has “Outperform” rating given on Wednesday, October 26 by Wolfe Research. KeyBanc Capital Markets maintained it with “Buy” rating and $100.0 target in Friday, September 15 report. Longbow downgraded Westinghouse Air Brake Technologies Corp (NYSE:WAB) on Wednesday, October 26 to “Neutral” rating. The firm has “Buy” rating by Stifel Nicolaus given on Monday, December 21. Deutsche Bank maintained Westinghouse Air Brake Technologies Corp (NYSE:WAB) on Monday, August 14 with “Hold” rating. The firm has “Gradually Accumulate” rating given on Friday, April 7 by Wellington Shields. The firm earned “Hold” rating on Wednesday, July 26 by Edward Jones. Buckingham Research maintained Westinghouse Air Brake Technologies Corp (NYSE:WAB) on Wednesday, October 25 with “Buy” rating. Berenberg initiated Westinghouse Air Brake Technologies Corp (NYSE:WAB) on Thursday, September 7 with “Hold” rating. The firm earned “Overweight” rating on Wednesday, April 26 by KeyCorp.

Loring Wolcott & Coolidge Fiduciary Advisors Llp decreased Abbott Laboratories (NYSE:ABT) stake by 35,783 shares to 2.09 million valued at $102.86 million in 2017Q2. It also reduced Cognizant Technology Solutions (NASDAQ:CTSH) stake by 12,941 shares and now owns 1.75M shares. General Mills Inc (NYSE:GIS) was reduced too.